|
State Department |
|
|
Programme |
|
|
Sub Programme |
|
|
Allocation: |
KES 901,356,543.00 (R) |
Key Performance Indicators (Targets)
Key Output |
KPI |
Target Yr (2024) |
Target Yr (2025) |
Target Yr (2026) |
|---|---|---|---|---|
Audit Services |
No. of value for money (VFM) Audit reports |
280 |
280 |
285 |
Audit Services |
No. of Government Entities capacity built on IRMF |
30 |
30 |
30 |
Audit Services |
No. of Audit Committees Capacity built |
20 |
20 |
20 |
Audit Services
No. of value for money (VFM) Audit reports
2024
280
2025
280
2026
285
Audit Services
No. of Government Entities capacity built on IRMF
2024
30
2025
30
2026
30
Audit Services
No. of Audit Committees Capacity built
2024
20
2025
20
2026
20
Previous Year Allocations
Num |
Year |
Total |
|---|---|---|
1 |
KES 927,012,661.00 |
|
2 |
KES 901,356,543.00 |
|
3 |
KES 1,099,247,642.00 |
|
4 |
KES 812,329,038.00 |
|
5 |
KES 741,113,289.00 |
User Uploads
No. of PPP projects approved: 12
KES 86,537,104.00
KES 83,748,179.00
(2024)
Funds disbursed to MDAs as a % of the external resources mobilized: 100
KES 204,365,629.00
(2024)
No. of patients receiving Anti- retroviral Therapy (ART) supplies (millions): 1.3
KES 22,520,960.00
(2024)